RT-PCR Market Size, Share, and Growth Analysis by 2031
RT-PCR Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
- Report Date : Jan 2026
- Report Code : TIPRE00042220
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 282
The RT-PCR market size is projected to reach US$ 2.71 billion by 2031 from US$ 4.47 billion in 2024. The market is expected to register a CAGR of 7.5% during 2025–2031.
RT-PCR Market AnalysisRT-PCR is a widely preferred test in molecular diagnostics due to its high sensitivity and specificity. Despite reductions in COVID-19 mass testing, demand for RT-PCR continues to grow due to infectious disease surveillance, oncology, genetic testing, and respiratory viral multiplex panels.
Advanced testing features, including automation, shorter turnaround times, and integration with other syndromic testing platforms, enhance RT-PCR efficiency and accelerate speed to market. The growing availability of RT-PCR systems in emerging markets and ongoing global pathogen circulation are driving the need for a robust worldwide RT-PCR infrastructure.
RT-PCR Market OverviewRT-PCR enables rapid and sensitive detection of pathogens, genetic mutations, and gene expression. RT-PCR is primarily used for infectious disease testing, such as detecting respiratory viruses and HIV, as well as for oncology and biomarker profiling. It is also applied in genetic screening and research.
Major companies in this space are Thermo Fisher Scientific, Roche, Bio-Rad, QIAGEN, and Abbott. They provide product offerings including instruments, reagents, and kits. Innovative advancements include multiplex assays, digital PCR integration, and point-of-care systems to generate quicker results. North America leads the market due to strong research and development activity and support from regulatory agencies. Europe and Asia Pacific have been witnessing an increase in the prevalence of chronic and infectious diseases and are gradually catching up to North America. Current market trends include automation, artificial intelligence-enhanced analysis, and portable devices for decentralized testing.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
RT-PCR Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Drivers:
- Infectious disease surveillance: Continuous circulation of respiratory, emerging, and endemic pathogens sustains demand for accurate, multiplex RT-PCR testing.
- Technological advancements: Automation, high-throughput platforms, and faster turnaround times improve laboratory efficiency, scalability, and adoption across clinical and public health settings.
Market Opportunities:
- Multiplex respiratory testing expansion: Growing need to simultaneously detect influenza, RSV, SARS-CoV-2, and emerging pathogens creates sustained demand for advanced RT-PCR panels.
- Emerging Markets Expansion: Expansion of near-patient testing in clinics and resource-limited settings opens new markets for compact, automated RT-PCR platforms.
The RT-PCR market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:
By Product:
- Reagents & Consumables: The reagents and consumables segment is growing due to repeated purchases of RT-PCR kits and enzymes driven by ongoing illnesses and continuous monitoring needs.
- Instruments: The instruments segment is growing due to increased laboratory automation, replacement of older laboratory systems, and rising demand for molecular diagnostics in clinical, research, and public health laboratories.
- Software & Services: The growth of the software and services segment is driven by rising demand for RT-PCR result analysis and automation, along with service support and seamless integration with laboratory information systems.
By Application:
- Research Application: The research application segment is driven by the increased use of RT-PCR in genomics, gene expression studies, biomarker discovery, and academic and pharmaceutical research advancements.
- Clinical Application: The clinical application segment is growing due to rising demand for accurate molecular diagnostics in infectious diseases, oncology, genetic testing, and routine hospital laboratory testing worldwide. The clinical application segment is further sub-segmented into oncology testing, blood screening, infectious disease testing, and other applications.
- Forensic Application: The forensic application segment is growing due to the increasing use of RT-PCR in DNA analysis, crime investigation, human identification, and sensitive detection of biological evidence.
By End User:
- Hospitals and Diagnostic Centers
- Pharmaceutical and Biotechnology Companies
- Research Laboratories and Academic Institutes
- Forensic Laboratories
- Clinical Research Organizations
By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America leads the global RT-PCR market due to advanced healthcare infrastructure, high research investment, strong diagnostic testing demand, and the presence of major biotech and diagnostic companies driving adoption across clinical and research applications.
Europe follows as a major regional contributor, supported by well-established healthcare systems, proactive genetic and infectious disease testing initiatives, and extensive use of RT-PCR in clinical and research settings.
The market in Asia Pacific is growing at the fastest rate, propelled by expanding healthcare access, rising demand for molecular diagnostics, government health investments, and increasing laboratory capacity in countries such as China, India, and Japan.
Latin America and Middle East & Africa represent emerging markets with growing demand as public health surveillance and diagnostic infrastructure improve. However, their current scale remains smaller compared with North America, Europe, and Asia Pacific.
Below is a summary of market share and trends by region:
1. North America
- Market Share: Holds a significant portion of the global market
- Key Drivers:
- Rising prevalence of cancer and demand for precision oncology diagnostics
- Persistent infectious disease threats and surveillance needs
- Trends: Shift toward digital PCR and multiplex assays for enhanced sensitivity
2. Europe
- Market Share: Holds a substantial market share
- Key Drivers:
- Escalating cancer incidence is fueling demand for molecular oncology diagnostics
- Persistent antimicrobial resistance and respiratory infections are driving surveillance needs
- Trends: Adoption of digital PCR and multiplex assays for enhanced precision.
3. Asia Pacific
- Market Share: Fastest-growing region with a steadily increasing market share each year.
- Key Drivers:
- Rapidly rising cancer incidence is driving molecular oncology diagnostics
- Endemic infectious diseases and outbreak preparedness are driving increased surveillance.
- Trends: Adoption of digital PCR and multiplex assays for high-throughput applications.
4. South and Central America
- Market Share: Growing market with steady progress
- Key Drivers:
- High infectious disease burden
- Investment in healthcare infrastructure and diagnostics
- Trends: Shift toward decentralized and rapid testing
5. Middle East and Africa
- Market Share: Holds a small market share, growing at a rapid pace
- Key Drivers:
- Rising infectious and genetic disease burden
- Substantial investments in healthcare infrastructure
- Trends: Shift toward decentralized and point-of-care testing.
High Market Density and Competition
Competition is strong due to the presence of established players such as Abbott Laboratories and Takara Bio Inc. Niche providers also contribute to the competitive landscape across regions.
This high level of competition urges companies to stand out by offering:
- Advanced Products
- Value-added services such as customization and sustainable solutions
- Competitive pricing models
- Compliance with regulatory guidelines
Opportunities and Strategic Moves
- Bio-Rad launched its CFX Opus Deepwell Dx real-time PCR system, an open platform for developing in vitro diagnostic assays. The system multiplexes up to five targets and allows reaction volumes up to 125 µL in a 96-well format for quantitative PCR diagnostic assays. CFX Maestro Dx SE software provides data management and analysis tools.
- Roche launched a next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges.
- Abbott
- Qiagen
- Bio-Rad Laboratories Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- GE Healthcare
- bioMérieux
- F. Hoffmann-La Roche Ltd
- Takara Bio Inc
- Genome Diagnostics Pvt Ltd
Disclaimer: The companies listed above are not ranked in any particular order.
Other companies analyzed during the course of research:
- Danaher Corporation (Cepheid)
- PerkinElmer, Inc.
- Promega Corporation
- Seegene Inc.
- Eurofins Scientific
- Meridian Bioscience, Inc.
- Microsynth AG
- Altona Diagnostics GmbH
- Bio-Techne Corporation
- Luminex Corporation
- Wikipedia
- Analytik Jena AG
- Bioneer Corporation
- Hologic Inc.
- Becton Dickinson & Company (BD)
- DiaSorin S.p.A.
- BGI Genomics Co., Ltd.
- Sysmex Inostics GmbH
- QuantuMDx Group
- Co-Diagnostics (CoDx)
- GeneDireX, Inc
- Takara Bio launches a high-throughput, cost-effective qPCR system to advance clinical research in November 2024.: Takara Bio USA, Inc. announced the launch of the SmartChip ND Real-Time PCR System, an automated, research-use-only, high-throughput qPCR solution for infectious disease research. Takara Bio USA is now accepting orders of the SmartChip ND Real-Time PCR System.
- BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec in December 2025.: BD announced the expansion of its respiratory and sexually transmitted infection (STI) diagnostics offerings in Europe following In Vitro Diagnostic Medical Device Regulation (IVDR) certification of two VIASURE assays developed by Certest Biotec for use on the BD MAX™ System. The addition of these new assays to the BD MAX™ System portfolio enables clinical laboratories to detect a broad range of pathogens quickly and accurately using a fully automated molecular platform.
The "RT-PCR Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- RT-PCR Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- RT-PCR Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- RT-PCR Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the RT-PCR Market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the market in 2024.
Factors driving the RT-PCR market include surging global infectious disease outbreaks necessitating rapid diagnostic capabilities, and escalating cancer incidence driving oncogene detection and personalized diagnostics.
The RT-PCR market is estimated to register a CAGR of 7.5% during the forecast period.
The RT-PCR market is estimated to reach US$ 4.47 billion by 2031.
Abbott, Qiagen, Bio-Rad Laboratories Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, bioMérieux, F. Hoffmann-La Roche Ltd, Takara Bio Inc., and Genome Diagnostics Pvt Ltd are among the key players operating in the RT-PCR market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. RT-PCR Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. RT-PCR Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Surging Global Infectious Disease Outbreaks Necessitating Rapid Diagnostic Capabilities
5.1.2 Escalating Cancer Incidence Driving Oncogene Detection and Personalized Diagnostics
5.1.3 Advancing Genetic Testing for Precision Medicine and Hereditary Disorders
5.2 Market Restraints
5.2.1 High Costs and Limited Accessibility of RT-PCR Testing Kits
5.2.2 Supply Chain Disruptions and Shortage of Reagents and Consumables
5.2.3 Regulatory Challenges and Lengthy Approval Processes
5.3 Market Opportunities
5.3.1 Expansion in Point-of-Care RT-PCR for Rapid Infectious Disease Response
5.3.2 Integration of RT-PCR in Oncology for Biomarker-Driven Personalized Medicine
5.3.3 Advancements in RT-PCR for Genetic Screening and Precision Health
5.4 Future Trends
5.4.1 Increasing Adoption of Multiplex RT-PCR Assays
5.4.2 Integration of Point-of-Care and Portable RT-PCR Devices
5.4.3 Advances in Automated and High-Throughput RT-PCR Technologies
5.5 Impact Analysis:
6. RT-PCR Market - Global Market Analysis
6.1 RT-PCR Market Revenue (US$ Mn), 2021 – 2031
7. Global RT-PCR Market – Revenue and Forecast to 2031 – by Product
7.1 Overview
7.2 RT-PCR Market Revenue Share, by Product, 2021 & 2031(%)
7.3 Reagents & Consumables
7.3.1 Overview
7.3.2 Reagents & Consumables: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
8. Global RT-PCR Market – Revenue and Forecast to 2031 – by Application
8.1 Overview
8.2 RT-PCR Market Revenue Share, by Application, 2021 & 2031(%)
8.3 Research Application
8.3.1 Overview
8.3.2 Research Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Clinical Application
8.4.1 Overview
8.4.2 Clinical Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
8.4.2.1 RT-PCR Market, by Clinical Application, 2021–2031 (US$ Million)
8.5 Forensic Application
8.5.1 Overview
8.5.2 Forensic Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9. Global RT-PCR Market – Revenue and Forecast to 2031 – by End-User
9.1 Overview
9.2 RT-PCR Market Revenue Share, by End-User, 2021 & 2031(%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Research Laboratories and Academic Institutes
9.5.1 Overview
9.5.2 Research Laboratories and Academic Institutes: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Forensic Laboratories
9.6.1 Overview
9.6.2 Forensic Laboratories: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9.7 Clinical Research Organizations
9.7.1 Overview
9.7.2 Clinical Research Organizations: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
10. RT-PCR Market - Geographical Analysis
10.1 North America RT-PCR Market, Revenue and Forecast To 2031
10.1.1 Overview
10.1.2 North America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.3 North America: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.1.4 North America: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.1.4.1 North America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5 North America: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.1.5.1 North America RT-PCR Market, by Country
10.1.5.2 US
10.1.5.2.1 US RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.2.2 US: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.1.5.2.3 US: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.1.5.2.4.1 US: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.2.5 US: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.1.5.3 Canada
10.1.5.3.1 Canada RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.3.2 Canada: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.1.5.3.3 Canada: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.1.5.3.4.1 Canada: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.3.5 Canada: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.1.5.4 Mexico
10.1.5.4.1 Mexico RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.4.2 Mexico: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.1.5.4.3 Mexico: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.1.5.4.3.1 Mexico: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.4.4 Mexico: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2 Europe RT-PCR Market, Revenue and Forecast to 2031
10.2.1 Overview
10.2.2 Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.3 Europe: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.4 Europe: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.4.1 Europe: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5 Europe: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.1 Europe RT-PCR Market, by Country
10.2.5.2 UK
10.2.5.2.1 UK RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.2.2 UK: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.2.3 UK: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.2.3.1 UK: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.2.4 UK: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.3 Germany
10.2.5.3.1 Germany RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.3.2 Germany: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.3.3 Germany: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.3.3.1 Germany: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.3.4 Germany: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.4 France
10.2.5.4.1 France RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.4.2 France: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.4.3 France: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.4.3.1 France: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.4.4 France: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.5 Italy
10.2.5.5.1 Italy RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.5.2 Italy: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.5.3 Italy: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.5.3.1 Italy: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.5.4 Italy: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.6 Spain
10.2.5.6.1 Spain RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.6.2 Spain: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.6.3 Spain: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.6.3.1 Spain: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.3.5 Spain: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.7 Rest of Europe
10.2.5.7.1 Rest of Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.7.2 Rest of Europe: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.7.3 Rest of Europe: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.7.3.1 Rest of Europe: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.7.4 Rest of Europe: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3 Asia Pacific RT-PCR Market, Revenue and Forecast to 2031
10.3.1 Overview
10.3.2 Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.3 Asia Pacific: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.4 Asia Pacific: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.4.1 Asia Pacific: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5 Asia Pacific: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.1 Asia Pacific RT-PCR Market, by Country
10.3.5.2 China
10.3.5.2.1 China RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.2.2 China: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.2.3 China: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.2.3.1 China: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.2.4 China: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.3 Japan
10.3.5.3.1 Japan RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.3.2 Japan: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.3.3 Japan: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.3.3.1 Japan: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.3.4 Japan: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.4 India
10.3.5.4.1 India RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.4.2 India: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.4.3 India: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.4.3.1 India: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.4.4 India: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.5 Australia
10.3.5.5.1 Australia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.5.2 Australia: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.5.3 Australia: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.5.3.1 Australia: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.5.4 Australia: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.6 South Korea
10.3.5.6.1 South Korea RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.6.2 South Korea: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.6.3 South Korea: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.6.3.1 South Korea: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.6.4 South Korea: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.7 Rest of Asia Pacific
10.3.5.7.1 Rest of Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.7.2 Rest of Asia Pacific: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.7.3 Rest of Asia Pacific: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.7.3.1 Rest of Asia Pacific: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.7.4 Rest of Asia Pacific: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.4 Middle East & Africa RT-PCR Market, Revenue and Forecast to 2031
10.4.1 Overview
10.4.2 Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.4.3 Middle East & Africa: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.4.4 Middle East & Africa: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.4.4.1 Middle East & Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.4.5 Middle East & Africa: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.1 Middle East & Africa RT-PCR Market, by Country
10.3.5.2 Saudi Arabia
10.3.5.2.1 Saudi Arabia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.2.2 Saudi Arabia: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.2.3 Saudi Arabia: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.2.3.1 Saudi Arabia: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.2.4 Saudi Arabia: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.3 UAE
10.3.5.3.1 UAE RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.3.2 UAE: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.3.3 UAE: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.3.3.1 UAE: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.3.5 UAE: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.4 South Africa
10.3.5.4.1 South Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.4.2 South Africa: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.4.3 South Africa: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.4.3.1 South Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.4.4 South Africa: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.5 Rest of Middle East & Africa
10.3.5.5.1 Rest of Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.5.2 Rest of Middle East & Africa: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.5.3 Rest of Middle East & Africa: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.5.3.1 Rest of Middle East & Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.5.4 Rest of Middle East & Africa: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.5 South & Central America RT-PCR Market, Revenue and Forecast to 2031
10.5.1 Overview
10.5.2 South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.3 South & Central America: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.5.4 South & Central America: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.5.4.1 South & Central America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5 South & Central America: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.5.5.1 South & Central America RT-PCR Market, by Country
10.5.5.2 Brazil
10.5.5.2.1 Brazil RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.2.2 Brazil: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.5.5.2.3 Brazil: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.5.5.2.3.1 Brazil: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.2.4 Brazil: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.5.5.3 Argentina
10.5.5.3.1 Argentina RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.3.2 Argentina: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.5.5.3.3 Argentina: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.5.5.3.3.1 Argentina: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.3.4 Argentina: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.5.5.4 Rest of South & Central America
10.5.5.4.1 Rest of South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.4.2 Rest of South & Central America: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.5.5.4.3 Rest of South & Central America: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.5.5.4.3.1 Rest of South & Central America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.4.4 Rest of South & Central America: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
11. RT-PCR Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in RT-PCR Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Takara Bio Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Qiagen NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hologic Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 bioMerieux SALtd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 F. Hoffmann-La Roche Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bio-Rad Laboratories Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Agilent Technologies Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Promega CorpPvt Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 SWOT Analysis
12.10.5 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. RT-PCR Market Segmentation
Table 2. RT-PCR Market, by Clinical Application – Revenue and Forecast to 2031 (US$ Million)
Table 3. North America RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 4. North America RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 5. North America RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 6. North America RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 7. US RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 8. US RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 9. US RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 10. US RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 11. Canada RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 12. Canada RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 13. Canada RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 14. Canada RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 15. Mexico RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 16. Mexico RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 17. Mexico RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 18. Mexico RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 19. Europe RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 20. Europe RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 21. Europe RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 22. Europe RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 23. UK RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 24. UK RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 25. UK RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 26. UK RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 27. Germany RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 28. Germany RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 29. Germany RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 30. Germany RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 31. France RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 32. France RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 33. France RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 34. France RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 35. Italy RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 36. Italy RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 37. Italy RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 38. Italy RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 39. Spain RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 40. Spain RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 41. Spain RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 42. Spain RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 43. Rest of Europe RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 44. Rest of Europe RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 45. Rest of Europe RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 46. Rest of Europe RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 47. Asia Pacific RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 48. Asia Pacific RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 49. Asia Pacific RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 50. Asia Pacific RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 51. China RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 52. China RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 53. China RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 54. China RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 55. Japan RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 56. Japan RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 57. Japan RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 58. Japan RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 59. India RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 60. India RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 61. India RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 62. India RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 63. Australia RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 64. Australia RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 65. Australia RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 66. Australia RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 67. South Korea RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 68. South Korea RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 69. South Korea RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 70. South Korea RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 71. Rest of Asia Pacific RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 72. Rest of Asia Pacific RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 73. Rest of Asia Pacific RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 74. Rest of Asia Pacific RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 75. Middle East & Africa RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 76. Middle East & Africa RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 77. Middle East & Africa RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 78. Middle East & Africa RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 79. Saudi Arabia RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 80. Saudi Arabia RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 81. Saudi Arabia RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 82. Saudi Arabia RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 83. UAE RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 84. UAE RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 85. UAE RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 86. UAE RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 87. South Africa RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 88. South Africa RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 89. South Africa RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 90. South Africa RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 91. Rest of Middle East & Africa RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 92. Rest of Middle East & Africa RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 93. Rest of Middle East & Africa RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 94. Rest of Middle East & Africa RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 95. South & Central America RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 96. South & Central America RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 97. South & Central America RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 98. South & Central America RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 99. Brazil RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 91. Brazil RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 92. Brazil RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 93. Brazil RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 94. Argentina RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 95. Argentina RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 96. Argentina RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 97. Argentina RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 98. Rest of South & Central America RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 99. Rest of South & Central America RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 100. Rest of South & Central America RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 101. Rest of South & Central America RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 102. Recent Organic Growth Strategies in RT-PCR Market
Table 103. Recent Inorganic Growth Strategies in the RT-PCR Market
Table 104. Glossary of Terms, RT-PCR Market
List of Figures
Figure 1. RT-PCR Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. RT-PCR Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. RT-PCR Market Revenue (US$ Mn), 2021 – 2031
Figure 6. RT-PCR Market Revenue, Geography (US$ Mn), 2021 – 2031
Figure 7. Quantitative PCR: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Digital PCR: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. RT-PCR Market Revenue Share, by Product, 2021 & 2031(%)
Figure 10. Reagents & Consumables: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Instruments: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Software & Services: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. RT-PCR Market Revenue Share, by Application, 2021 & 2031(%)
Figure 14. Research Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Clinical Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Forensic Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. RT-PCR Market Revenue Share, by End-User, 2021 & 2031(%)
Figure 18. Hospitals and Diagnostic Centers: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 19. Pharmaceutical and Biotechnology Companies: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Research Laboratories and Academic Institutes: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Forensic Laboratories: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Clinical Research Organizations: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. North America: RT-PCR Market, by Key Country – Revenue (2022) (US$ Million)
Figure 24. North America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 25. North America RT-PCR Market, By Key Countries, 2022 and 2031 (%)
Figure 26. US RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 27. Canada RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 28. Mexico RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 29. Europe RT-PCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 30. Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 31. Europe RT-PCR Market, By Key Countries, 2022 and 2031 (%)
Figure 32. UK RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 33. Germany RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 34. France RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 35. Italy RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 36. Spain RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 37. Rest of Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 38. Asia Pacific RT-PCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 39. Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 40. Asia Pacific RT-PCR Market, By Key Countries, 2022 and 2031 (%)
Figure 41. China RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 42. Japan RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 43. India RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 44. Australia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 45. South Korea RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 46. Rest of Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 47. Middle East & Africa RT-PCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 48. Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 49. Middle East & Africa RT-PCR Market, By Key Countries, 2022 and 2031 (%)
Figure 50. Saudi Arabia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 51. UAE RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 52. South Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 53. Rest of Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 54. South & Central America RT-PCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 55. South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 56. South & Central America RT-PCR Market, By Key Countries, 2022 and 2031 (%)
Figure 57. Brazil RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 58. Argentina RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 59. Rest of South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
Figure 60. Growth Strategies in RT-PCR Market
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For